Page | 25
23. Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, et al. Comparative
Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Netw Open.
2020;3(2):e1920622.
24. Stone AC, Carroll JJ, Rich JD, Green TC. One year of methadone maintenance treatment in a fentanyl
endemic area: Safety, repeated exposure, retention, and remission. J Subst Abuse Treat. 2020;115:108031.
25. Farrell M, Ward J, Mattick R, Hall W, Stimson GV, des Jarlais D, et al. Methadone maintenance
treatment in opiate dependence: a review. BMJ. 1994;309(6960):997-1001.
26. Sun HM, Li XY, Chow EP, Li T, Xian Y, Lu YH, et al. Methadone maintenance treatment programme
reduces criminal activity and improves social well-being of drug users in China: a systematic review and
meta-analysis. BMJ Open. 2015;5(1):e005997.
27. Malta M, Varatharajan T, Russell C, Pang M, Bonato S, Fischer B. Opioid-related treatment,
interventions, and outcomes among incarcerated persons: A systematic review. PLoS Med.
2019;16(12):e1003002.
28. Ti L, Ti L. Leaving the Hospital Against Medical Advice Among People Who Use Illicit Drugs: A
Systematic Review. Am J Public Health. 2015;105(12):e53-9.
29. Wang SJ, Wade E, Towle J, Hachey T, Rioux J, Samuels O, et al. Effect of Inpatient Medication-
Assisted Therapy on Against-Medical-Advice Discharge and Readmission Rates. Am J Med. 2020.
30. Morin KA, Prevost CR, Eibl JK, Franklyn MT, Moise AR, Marsh DC. A retrospective cohort study
evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using
administrative data in Ontario, Canada. PLoS One. 2020;15(4):e0232191.
31. Jo Y, Nosal R, Vittori A, Cordova L, Vandever C, Alvarez C, et al. Effect of initiation of medications
for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private
hospital system in the United States, 2014-18. Addiction. 2021.
32. Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone
maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2:CD002207.
33. Srivastava A, Kahan M, Nader M. Primary care management of opioid use disorders: Abstinence,
methadone, or buprenorphine-naloxone? Can Fam Physician. 2017;63:200-5.
34. Canadian Research Initiative in Substance Misuse, editor. CRISM National Guideline for the Clinical
Management of Opioid Use Disorder2018.
35. Kakko J, Gronbladh L, Svanborg KD, von Wachenfeldt J, Ruck C, Rawlings B, et al. A stepped care
strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin
dependence: a randomized controlled trial. Am J Psychiatry. 2007;164(5):797-803.
36. Trafton JA, Minkel J, Humphreys K. Determining effective methadone doses for individual opioid-
dependent patients. PLoS Med. 2006;3(3):e80.
37. Beck T, Haasen C, Verthein U, Walcher S, Schuler C, Backmund M, et al. Maintenance treatment for
opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus
methadone. Addiction. 2014;109(4):617-26.
38. Arfken CL, Suchanek J, Greenwald MK. Characterizing fentanyl use in methadone-maintained
clients. J Subst Abuse Treat. 2017;75:17-21.
39. Parpouchi M, Moniruzzaman A, Rezansoff SN, Russolillo A, Somers JM. Characteristics of adherence
to methadone maintenance treatment over a 15-year period among homeless adults experiencing mental
illness. Addict Behav Rep. 2017;6:106-11.
40. Comer SD, Cahill CM. Fentanyl: Receptor pharmacology, abuse potential, and implications for
treatment. Neurosci Biobehav Rev. 2019;106:49-57.
41. British Columbia Centre on Substance Use, B.C. Ministry of Health. A Guideline for the Clinical
Management of Opioid Use Disorder. 2017.
42. College of Physicians and Surgeons of Saskatchewan. Opioid agonist therapy program: Standards
and guidelines for the treatment of opioid use disorder. Saskatoon, SK: College of Physicians and Surgeons
of Saskatchewan; 2018.
43. Baxter LE, Sr., Campbell A, Deshields M, Levounis P, Martin JA, McNicholas L, et al. Safe methadone
induction and stabilization: report of an expert panel. J Addict Med. 2013;7(6):377-86.
44. Verster A, Buning E. Methadone Guidelines. Amsterdam: Euro-Methwork; 2000.
45. Humeniuk R, Ali RL, White J, Hall W, Farrell M. Proceedings of Expert Workshop on the Induction
and Stabilisation of Patients Onto Methadone. Adelaide, South Australia: Commonwealth Deaprtment of
Health and Aged Care; 2000.